A detailed history of Voya Investment Management LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Voya Investment Management LLC holds 118,025 shares of QURE stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,025
Holding current value
$2 Million
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.78 - $10.12 $446,134 - $1.19 Million
118,025 New
118,025 $581,000
Q2 2023

Aug 14, 2023

SELL
$11.12 - $22.2 $163,686 - $326,784
-14,720 Reduced 48.7%
15,505 $177,000
Q1 2023

May 15, 2023

BUY
$18.7 - $23.07 $282,650 - $348,703
15,115 Added 100.03%
30,225 $608,000
Q3 2022

Nov 14, 2022

BUY
$16.98 - $25.54 $256,567 - $385,909
15,110 New
15,110 $283,000
Q2 2022

Aug 15, 2022

SELL
$13.15 - $20.45 $189,872 - $295,277
-14,439 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$20.24 - $36.01 $292,245 - $519,948
14,439 New
14,439 $299,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $793M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.